Page last updated: 2024-09-03

phytosphingosine and Benign Neoplasms

phytosphingosine has been researched along with Benign Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chung, HY; Kang, YH; Kim, CH; Lee, SJ; Lee, YS; Park, IC; Park, MT	1

Other Studies

1 other study(ies) available for phytosphingosine and Benign Neoplasms

Article	Year
Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells. Molecular cancer therapeutics, 2007, Volume: 6, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Mitochondria; Models, Biological; Neoplasms; Oxides; p38 Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerases; Protein Transport; Reactive Oxygen Species; Sphingosine	2007

Article

Year

Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells.

Molecular cancer therapeutics, 2007, Volume: 6, Issue:1

Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Mitochondria; Models, Biological; Neoplasms; Oxides; p38 Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerases; Protein Transport; Reactive Oxygen Species; Sphingosine

2007